EWTX

Edgewise Therapeutics, Inc.

NASDAQHealthcareBiotechnologyUS

Rating:C

CEO

Kevin Koch

IPO Date

2021-03-26

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

News SentimentBullish

Articles

Avg Positive

46.0%

Avg Negative

1.0%

Avg Neutral

52.3%

News Feed

Edgewise Therapeutics Reports First Quarter 2021 Financial Results and Recent Highlights

Edgewise Therapeutics Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters' Option to Purchase Additional Shares

EWTX Stock Price Increased 87.5% In Its Market Debut: Details